Filing Details
- Accession Number:
- 0001753763-20-000001
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-19 15:58:35
- Reporting Period:
- 2020-02-13
- Accepted Time:
- 2020-02-19 15:58:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
810509 | Navidea Biopharmaceuticals Inc. | NAVB | In Vitro & In Vivo Diagnostic Substances (2835) | 311080091 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1753763 | Jr. K John Scott | 5251 Dtc Parkway, Suite 285 Greenwood Village CO 80111 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-02-13 | 2,373,529 | $0.85 | 8,042,162 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 2,639 | Indirect | By Spouse |
Common Stock | 2,500 | Indirect | By Daughter |
Common Stock | 2,500 | Indirect | By Son |
Common Stock | 2,500 | Indirect | By Son |